ALK and lung adenocarcinoma: Here, we present a patient with locally advanced lung adenocarcinoma associated with <i>EML4</i>-<i>ALK</i> fusion mutation, who received neoadjuvant chemotherapy and alectinib treatment, and then underwent thoracoscopic left lower lung lobectomy.